CooperVision
CooperVision is a global soft contact lens manufacturer and wholly-owned business unit of The Cooper Companies (NASDAQ: COO), producing daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity, Avaira, MiSight) for licensed eye care professionals and patients across 130+ countries.
- Company typePublic
- Founded1980
- HeadquartersFairport, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What CooperVision does
CooperVision is one of the world's leading manufacturers of soft contact lenses, operating as a wholly-owned business unit of The Cooper Companies, Inc. (NASDAQ: COO) and serving licensed eye care professionals (optometrists and ophthalmologists) and their patients across more than 130 countries. The company holds an estimated 18-22% share of the global soft contact lens market and delivers prescription lenses for myopia, hyperopia, astigmatism, and presbyopia through five core product families — MyDay, clariti 1 day, Biofinity, Avaira Vitality, and MiSight 1 day — spanning daily disposable, two-week, and monthly replacement schedules, with a specialty eye care division (Blanchard Contact Lenses, Paragon Vision Sciences, and the SynergEyes hybrid lens franchise) addressing complex cases such as keratoconus and irregular corneas.
The company's technology stack is built on silicone hydrogel and hydrogel material platforms, with proprietary optical designs including ActivControl Technology (used in MiSight 1 day and demonstrated to reduce myopia progression in children by approximately 50%, with ~59% reduction over three years of clinical use) and Balanced Progressive Technology in Biofinity multifocal products. CooperVision manufactures at LEED-certified facilities in Alajuela, Costa Rica (Gold, >95% renewable electricity), Juana Diaz, Puerto Rico (Silver), and Scottsville, New York (Silver) — the latter two sites achieving ~30% lower greenhouse gas emissions per manufactured lens since 2021. The portfolio includes the only soft contact lens with myopia control indication approved in Japan, the United States, and China, and the company has introduced ISCC PLUS-certified bio-attributed plastic in packaging as the first contact lens manufacturer to do so.
CooperVision's business model is overwhelmingly a B2B2C hardware sales motion: lenses are sold to eye care professionals who prescribe and fit them, supplemented by a network of authorized U.S. distributors (ABB/CONCISE, Nassau Lens Co, New Era, Newton Group, Wisconsin Vision Associates) and a regional logistics centre in Singapore with CEVA Logistics serving Asia-Pacific. Marketing channels include the coopervision.com website with product education, a find-an-eye-doctor locator, free-trial offers, and patient rebate programs. Pricing is set at the practitioner level and not publicly disclosed; the company has begun layering in alternative revenue plays such as the easyvision private-label portfolio for IDOC alliance members (2026). CooperVision retains no AI/ML or software platform layer; its differentiation rests on materials science, clinical evidence, regulatory approvals, and global manufacturing/distribution reach.
CooperVision firmographics
Firmographics- Name
- CooperVision
- Legal name
- CooperVision, Inc.
- Website
- https://coopervision.com
- Company type
- Public
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- CooperVision is a global soft contact lens manufacturer and wholly-owned business unit of The Cooper Companies (NASDAQ: COO), producing daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity, Avaira, MiSight) for licensed eye care professionals and patients across 130+ countries.
- Ownership category
- akta.pro rank
CooperVision industry classification
Industry- Product category
- Contact Lenses
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)
Keywords
Where CooperVision is headquartered
LocationHeadquarters
- HQ city
- Fairport
- HQ country
- United States
- HQ region
- North America
Offices16 records
Markets served
CooperVision business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contact Lens Sales: CooperVision generates revenue through the sale of soft contact lenses across multiple product families including MyDay, Biofinity, clariti, Avaira, and MiSight. Products are sold to eye care professionals and through authorized distributors who then provide to patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Contact lenses sold through eye care professionals with various product families |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
CooperVision product offering
Product offeringCore offering
CooperVision manufactures and sells soft contact lenses across multiple product families including MyDay (daily disposable silicone hydrogel), clariti 1 day, Biofinity (monthly replacement), Avaira Vitality (two-week), and MiSight 1 day (myopia control for children). The company addresses all major vision correction needs including myopia, hyperopia, astigmatism, and presbyopia. Products are sold through eye care professionals and authorized distributors in 130+ countries.
Product overview
CooperVision is one of the world's leading contact lens manufacturers, offering a comprehensive portfolio of soft contact lenses across multiple product families. The company provides daily disposable lenses (MyDay®, clariti® 1 day), two-week lenses (Avaira Vitality™), and monthly replacement lenses (Biofinity®), available in spherical, toric for astigmatism, and multifocal for presbyopia options. CooperVision holds a unique position as the first and only company with FDA-approved myopia control technology through MiSight® 1 day for children. The product portfolio is built on silicone hydrogel material technology, emphasizing breathability, comfort, and oxygen transmission for eye health. Manufacturing facilities in Puerto Rico, Costa Rica, and New York are LEED-certified, with sustainability initiatives including the MADE BETTER™ Promise platform and plastic-neutral packaging through Plastic Bank partnerships. The company also manufactures private label products (easyvision™) and specialty lenses for keratoconus through the SynergEyes acquisition, serving eye care professionals and lens wearers in over 130 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Blanchard Vision Corp. Part of CooperVision Specialty EyeCare, specializing in gas-permeable and specialty contact lenses
- Paragon Vision Sciences
- MyDay
- clariti 1 day
- Biofinity
- Avaira Vitality
- MiSight 1 day
- MADE BETTER Promise
Products and services
- MyDay family Premium daily disposable silicone hydrogel contact lenses offering high oxygen transmission and all-day comfort. Includes spherical, toric, and multifocal options for vision correction needs.
- clariti 1 day family Daily disposable silicone hydrogel contact lenses offering breathable, comfortable wear with spherical, toric, and multifocal options for vision correction.
- Biofinity family Monthly replacement silicone hydrogel contact lenses offering premium comfort and breathability. Includes extended range (XR) options for higher prescriptions and multiple variants for astigmatism and presbyopia.
- Avaira Vitality family Two-week silicone hydrogel contact lenses offering high performance and value. Includes spherical and toric options for vision correction including astigmatism.
- MiSight 1 day Daily disposable myopia control contact lens for children aged 8-12 years. Uses ActivControl Technology to slow myopia progression by approximately 50%. First and only FDA-approved soft contact lens for myopia control in the US and Japan.
- easyvision Private label contact lens portfolio manufactured by CooperVision for IDOC member independent optometrist practices. Based on MyDay and clariti 1 day technologies, offered at lower prices than branded alternatives to help independent optometrists compete against online retailers.
- SynergEyes Hybrid Lenses Hybrid contact lens technology acquired through the SynergEyes Inc. acquisition. Designed for keratoconus treatments and specialty fitting applications for patients with irregular cornea conditions.
- CooperVision Specialty EyeCare (Blanchard, Paragon) Specialty eye care division providing specialty contact lenses including gas permeable, orthokeratology, hybrid, and scleral lenses through wholly-owned subsidiaries Blanchard Contact Lenses and Paragon Vision Sciences for complex vision correction needs.
Quantifiable outcome
- Approximately 50% reduction in myopia progression in children wearing MiSight 1 day vs single vision daily lenses
- +3 more outcomes
Companies that use CooperVision
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
CooperVision technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CooperVision partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered strategic and core.
- IDOCstrategicIDOC, a leading U.S. alliance for independent optometrist business owners, launched easyvision, a private label contact lens portfolio manufactured by CooperVision. The brand offers daily disposable lenses based on MyDay and clariti 1 day technologies at prices lower than branded alternatives, exclusively available to IDOC member practices.
- CEVA LogisticscoreCEVA Logistics and CooperVision launched a regional healthcare-focused logistics centre in Singapore's Airport Logistics Park to improve supply chain efficiency for eye care products across Asia Pacific. The facility adds up to 7,000 SKUs to the regional market, reducing fulfillment times and lowering costs. The partnership includes specialized healthcare infrastructure with GDP- and GMP-trained personnel and dedicated warehouse management systems.
- SynergEyes Inc.strategicIn January 2023, CooperVision acquired SynergEyes Inc. to expand its specialty contact lens portfolio with hybrid lens technology for keratoconus treatments. This acquisition enhanced CooperVision's capabilities in specialty lenses for irregular cornea conditions.
- Plastic BankcoreCooperVision's plastic neutrality program partnership with Plastic Bank enables collection and recycling of plastic bottles from coastal communities. Since January 2021, over 659 million plastic bottles have been collected from Indonesia, Egypt, and the Philippines. The partnership funds community development programs including health insurance, nutrition programs, and Wi-Fi access for collectors and their families.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
CooperVision competitors and assessment
Company assessmentBroad incumbents
- EssilorLuxottica: Global eyewear and lens giant (Ray-Ban, Oakley, Transitions, Stellest myopia control spectacle lens). Overlaps with CooperVision in vision correction and pediatric myopia management, and dominates the upstream optical retail channel CooperVision depends on.
- Carl Zeiss Meditec: Ophthalmic medical device and optics company with intraocular lenses, diagnostics, and surgical microscopy. Not a soft contact lens competitor but a comparable medical-device ophthalmic manufacturer serving ECPs globally.
Direct peers
- Bausch + Lomb: Major contact lens manufacturer (Biotrue, Ultra, SofLens) with parallel ECP distribution and direct-to-consumer channel. Comparable across soft lens families and specialty lenses.
- Hoya Corporation: Produces contact lenses and intraocular lenses through its Hoya Surgical Optics division. Comparable ophthalmic medical-device manufacturer with global distribution and a specialty IOL franchise adjacent to CooperVision's specialty lens business.
- Paragon Vision Sciences (now part of CooperVision): Specialty contact lens and orthokeratology manufacturer acquired by CooperVision. Operates within CooperVision Specialty EyeCare, providing gas-permeable and ortho-k lenses that compete with Euclid and Bausch + Lomb specialty products.
- Alcon: Global vision-care leader with Dailies, Air Optix, Precision, and PRECISION1 contact lens brands. Directly competes with CooperVision across daily disposable and monthly silicone hydrogel categories, plus broader ophthalmic surgical adjacency.
- SynergEyes (now part of CooperVision): Hybrid contact lens specialist for keratoconus and irregular corneas, acquired by CooperVision in January 2023. Operates as a specialty-lens brand within the CooperVision Specialty EyeCare division.
- Menicon: Japan-based contact lens manufacturer with strong APAC presence in daily disposable and specialty/orthokeratology lenses. Direct competitor in soft lenses and a natural comparator in the Japan myopia control market.
- Johnson & Johnson Vision: Largest global contact lens manufacturer through its Acuvue franchise (daily disposables, 2-week, monthly, toric, multifocal). Directly comparable soft-lens portfolio, ECP-channel go-to-market, and broad international regulatory footprint.
Emerging players
- Euclid Systems: Emerging player in orthokeratology (ortho-k) and myopia management contact lenses. Competes with CooperVision's Paragon and MiSight portfolios in the pediatric myopia control segment.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
CooperVision social profiles
Digital presenceCooperVision compliance and trust
Trust signalCompliance6 records
CooperVision financial estimates
Financial estimateRevenue estimate
Valuation estimate
CooperVision leadership team
Management profileNumber of profiles
Profiles7 records
CooperVision subsidiaries and ownership
Company hierarchySubsidiaries2 records
CooperVision funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CooperVision M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CooperVision
What does CooperVision do?
CooperVision manufactures and sells soft contact lenses across multiple product families including MyDay (daily disposable silicone hydrogel), clariti 1 day, Biofinity (monthly replacement), Avaira Vitality (two-week), and MiSight 1 day (myopia control for children). The company addresses all major vision correction needs including myopia, hyperopia, astigmatism, and presbyopia. Products are sold through eye care professionals and authorized distributors in 130+ countries.
Is CooperVision a public or private company?
CooperVision is a public company. It is classified as public and is currently operating.
When was CooperVision founded?
CooperVision was founded in 1980. It employs 1,001 to 5,000 people.
Where is CooperVision based?
CooperVision is headquartered in Fairport, United States, in the North America region.
How does CooperVision make money?
One revenue line is on record: contact Lens Sales.
Who are CooperVision's main competitors?
Broad incumbents on record are EssilorLuxottica and Carl Zeiss Meditec. Direct peers are Bausch + Lomb, Hoya Corporation, Paragon Vision Sciences (now part of CooperVision), Alcon, SynergEyes (now part of CooperVision), Menicon and Johnson & Johnson Vision. Euclid Systems is listed as an emerging player.
Does CooperVision have an API?
No public API is recorded for CooperVision.
What industry is CooperVision in?
CooperVision's product category is Contact Lenses. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions). Its NAICS code is 339115 and its SIC code is 3851.